MedPath

Brain fMRT In Takotsubo Cardiomyopathy

Completed
Conditions
Takotsubo Cardiomyopathy
Registration Number
NCT02240056
Lead Sponsor
Wolfgang Dichtl, MD PhD
Brief Summary

Certain cardiac and neurologic diseases influence each other via a still poorly understood "brain-heart axis". Subarachnoidal bleedings are well known to cause ECG alterations resembling those of myocardial infarction, along with a reduction of systolic myocardial function ("neurogenic stunned myocardium"). Alterations of the right insula region by a stroke or intracranial hemorrhage go along with a sympathetic activation (increased circulating catecholamine levels, tachycardia, arterial hypertension). In contrast, alterations of the left insula region often cause vagal reactions such as bradycardia, arterial hypotension. Takotsubo cardiomyopathy (TTC) is a just recently recognised subform of heart attacks, often caused by psychological or physical stress (death of a beloved one, divorce, job loss, infection, preoperative state). In more than 90% of cases, TTC affects postmenopausal women.

Functional MRT enables imaging of activated brain regions, either without ("resting state") or with specific stimuli. The investigators speculate that there is a specific involvement of the insula region during TTC.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
55
Inclusion Criteria
  • Postmenopausal females aged below 90 years
  • Informed written consent
  • TTC or NSTEMI / STEMI undergoing coronary angiography within 24 hours of symptom onset
Exclusion Criteria
  • Delayed coronary angiography (> 24 hours after symptom onset)
  • Inability to perform rsfMRT within the first 72 hours after coronary angiography
  • Inability to communicate in German language
  • Contraindications for a MRT examination (including pacemaker, implantable cardioverter-defibrillator, mechanical heart valves, claustrophobia, severe adipositas)
  • Drug addiction, under guardianship
  • Inability to stick to the follow up examination

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in brain functional MRT (resting state, paradigma) in postmenopausal females suffering from TTC as compared to NSTEMI / STEMI postmenopausal female patientsWithin the first 72h after diagnosis and after 4-8 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Medical University Innsbruck

🇦🇹

Innsbruck, Tirol, Austria

© Copyright 2025. All Rights Reserved by MedPath